Linked Data API

Show Search Form

Search Results

100423
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Alcoholic Drinks: Labelling more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, what assessment he has made of the effect of mandatory labelling on all alcoholic products on the incidence of foetal alcohol spectrum disorders; and if he will make a statement. more like this
star this property tabling member constituency Hazel Grove more like this
star this property tabling member printed
Sir Andrew Stunell more like this
star this property uin 211414 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>The Government is committed to improving the labelling of alcoholic drinks, including a warning to avoid alcohol for women who are pregnant or trying to conceive. It is not mandatory to include warnings on drinking in pregnancy on labels. However, as part of the Public Health Responsibility Deal, alcohol retailers and producers have a responsibility to help raise this awareness and have committed to putting an agreed warning or a pregnancy warning logo on 80% of labels on bottles and cans.</p><p> </p><p>An independent market survey has been carried out which we expect to be published shortly.</p><p> </p><p> </p><p> </p><p>The evidence is that health information on labels should not be considered a standalone measure, but part of broader efforts to raise consumer awareness and education on the health risks linked to alcohol consumption.</p><p> </p><p> </p><p> </p><p>This is supported by research commissioned by the Department in 2005 to review the evidence around the effectiveness of alcohol harm reduction communications and related campaigns.</p><p> </p><p><strong> </strong></p><p> </p><p>The Chief Medical Officer is currently overseeing a United Kingdom-wide review of all alcohol guidelines so that people can make informed choices about their drinking at all stages of their lives.</p><p> </p><p> </p><p> </p><p>The review will specifically include consideration of health risks for women from alcohol consumption. We expect to be able to consult on new draft guidelines by summer 2015.</p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T17:00:37.8229997Zmore like thismore than 2014-10-29T17:00:37.8229997Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
445
unstar this property label Biography information for Lord Stunell more like this
100422
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Dietary Supplements more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, what recent representations the Government has made to the European Commission on the future regulation of health food supplements. more like this
star this property tabling member constituency Belfast North more like this
star this property tabling member printed
Mr Nigel Dodds more like this
star this property uin 211418 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>The United Kingdom has not recently made any representations to the European Commission on the future of health food supplements.</p><p> </p><p> </p><p> </p><p>Officials continue to engage at European Commission Expert Working Group meetings to ensure that any future changes to legislation are proportionate and based on evidence, so that consumers have confidence in what they buy, while maintaining a wide choice of safe products.</p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T17:25:55.3605703Zmore like thismore than 2014-10-29T17:25:55.3605703Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1388
unstar this property label Biography information for Lord Dodds of Duncairn more like this
100426
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Cord Blood more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, what recent discussions his Department has had with NHS Trusts on (a) increasing the number of hospitals that are able to collect umbilical cord blood for transport and (b) promoting the donation of umbilical cord blood for transplant. more like this
star this property tabling member constituency Wolverhampton South West more like this
star this property tabling member printed
Paul Uppal more like this
star this property uin 211439 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>NHS Blood and Transport (NHSBT) manages the NHS Cord Blood Bank and provides specialist services related to the provision of stem cells which can turn into blood cells for the treatment of blood cancers. This service is an integral part of the Anthony Nolan and NHS Stem Cell Registry. NHSBT is also responsible for raising awareness of these issues, in collaboration with its delivery partners. NHSBT has informed the Department that it has no plans to open new collection centres at present.</p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T17:40:05.1595515Zmore like thismore than 2014-10-29T17:40:05.1595515Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4078
unstar this property label Biography information for Paul Uppal more like this
100400
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Pancreatic Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS improves the diagnosis and treatment of pancreatic cancer. more like this
star this property tabling member constituency Birkenhead more like this
star this property tabling member printed
Mr Frank Field more like this
star this property uin 211514 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>Achieving earlier diagnosis of cancer is key to our ambition to save an additional 5,000 lives per year by 2014-15. We are investing £450 million to achieve early diagnosis of cancer through better public awareness, better screening and better access to key diagnostic tests. However we know that early diagnosis of pancreatic cancer can be very difficult as the symptoms are shared with a wide range of benign conditions.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) Referral Guidelines for Suspected Cancer (2005) are available to help general practitioners assess when it is appropriate to refer patients for suspected cancer, including pancreatic cancer. NICE is in the process of updating the guidelines to ensure that these reflect latest evidence and can continue to support general practitioners (GPs) to identify patients with suspected cancer symptoms and urgently refer them as appropriate. NICE’s anticipated publication date for the revised guidelines is May 2015.</p><p> </p><p> </p><p> </p><p>We understand that NHS England has asked NICE to develop a clinical guideline and quality standard on pancreatic cancer.</p><p> </p><p> </p><p> </p><p>At a local level, it is for individual clinical commissioning groups to promote and enhance the diagnostic capability to deliver better outcomes. Surgery, radiotherapy and chemotherapy treatments that may be used for pancreatic cancer are commissioned at the moment by NHS England. NHS England’s pancreatic cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective pancreatic cancer services. This service specification has been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe core and developmental service standards.</p><p> </p><p> </p><p> </p><p>NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK into the use of Stereotactic Ablative Radiotherapy (SABR), an innovative radiotherapy treatment. This will allow patients to receive SABR treatment now, where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of these treatments so that in future, if it proves to be effective, they will be available for all relevant patients on the NHS. One of these six trials will be on pancreatic cancer.</p><p> </p><p><strong> </strong></p><p> </p><p>The Department published Improving Outcomes for Upper Gastro-Intestinal Cancers in 2001, which describes best practice in the delivery of services for patients with all types of upper gastro-intestinal cancer, including pancreatic cancer.<br> <br> NICE has recommended gemcitabine as a treatment option for pancreatic cancer in technology appraisal guidance published in May 2001, subject to certain clinical criteria and is currently appraising a number of other pancreatic cancer drugs. Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate. <br> <br> A number of drugs to treat pancreatic cancers are also available through the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T16:58:52.2238191Zmore like thismore than 2014-10-29T16:58:52.2238191Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
478
unstar this property label Biography information for Lord Field of Birkenhead more like this
100401
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Motor Neurone Disease more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS is meeting the communication needs of people with motor neurone disease. more like this
star this property tabling member constituency Birkenhead more like this
star this property tabling member printed
Mr Frank Field more like this
star this property uin 211515 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>Since 1 April 2013 NHS England has been responsible for commissioning Alternative and Augmentative Communication (AAC) aids for patients with complex disability whose needs require specialised assessment, including for patients with motor neurone disease. Commissioning of non-specialised AAC aids is the responsibility of local clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England has published a service specification for specialised AAC aids that sets out what should be in place for providers to offer evidence-based, safe and effective services. The specification can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf</a></p><p> </p><p> </p><p> </p><p>NHS England has identified an additional £22.5 million funding for AAC and Environmental Controls in 2014-15. They have been working closely with the Motor Neurone Disease Association (MNDA) to ensure this funding is equitably distributed across England in a fair and consistent manner. The MNDA are representing all patients on the panel which is reviewing this funding allocation.</p><p> </p>
star this property answering member constituency North Norfolk more like this
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-10-29T17:16:16.5530137Zmore like thismore than 2014-10-29T17:16:16.5530137Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
478
unstar this property label Biography information for Lord Field of Birkenhead more like this
100405
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Obesity: Pendle more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, how many children in Pendle constituency were classified as (a) overweight and (b) obese in each year since 2006-07. more like this
star this property tabling member constituency Pendle more like this
star this property tabling member printed
Andrew Stephenson more like this
star this property uin 211555 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>Data on childhood obesity are not collected by parliamentary constituency. The following data are for the area of Pendle district. The National Childhood Measurement Programme (NCMP) data collection began in 2006-07 and only collects data on two age groups; reception year (4-5 years) and year 6 (10-11 years).</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td colspan="4"><p>Reception Year (4-5 years)</p></td><td colspan="4"><p>Year 6 (10-11 years)</p></td></tr><tr><td><p> </p></td><td colspan="2"><p>Prevalence of obesity</p></td><td colspan="2"><p>Prevalence of overweight (including obese)</p></td><td colspan="2"><p>Prevalence of obesity</p></td><td colspan="2"><p>Prevalence of overweight (including obese)</p></td></tr><tr><td><p> </p></td><td><p>Children</p></td><td><p>%</p></td><td><p>Children</p></td><td><p>%</p></td><td><p>Children</p></td><td><p>%</p></td><td><p>Children</p></td><td><p>%</p></td></tr><tr><td><p>2006-07</p></td><td><p>94</p></td><td><p>10.84</p></td><td><p>191</p></td><td><p>22.03</p></td><td><p>50</p></td><td><p>13.59</p></td><td><p>99</p></td><td><p>26.9</p></td></tr><tr><td><p>2007-08</p></td><td><p>89</p></td><td><p>10.06</p></td><td><p>193</p></td><td><p>21.81</p></td><td><p>152</p></td><td><p>18.36</p></td><td><p>251</p></td><td><p>30.31</p></td></tr><tr><td><p>2008-09</p></td><td><p>82</p></td><td><p>7.98</p></td><td><p>219</p></td><td><p>21.32</p></td><td><p>159</p></td><td><p>16.31</p></td><td><p>279</p></td><td><p>28.62</p></td></tr><tr><td><p>2009-10</p></td><td><p>102</p></td><td><p>9.51</p></td><td><p>253</p></td><td><p>23.58</p></td><td><p>175</p></td><td><p>17.82</p></td><td><p>307</p></td><td><p>31.26</p></td></tr><tr><td><p>2010-11</p></td><td><p>106</p></td><td><p>9.84</p></td><td><p>256</p></td><td><p>23.77</p></td><td><p>163</p></td><td><p>17.25</p></td><td><p>291</p></td><td><p>30.79</p></td></tr><tr><td><p>2011-12</p></td><td><p>115</p></td><td><p>10.48</p></td><td><p>271</p></td><td><p>24.7</p></td><td><p>192</p></td><td><p>19.12</p></td><td><p>352</p></td><td><p>35.06</p></td></tr><tr><td><p>2012-13</p></td><td><p>151</p></td><td><p>12.46</p></td><td><p>313</p></td><td><p>25.83</p></td><td><p>188</p></td><td><p>19.54</p></td><td><p>339</p></td><td><p>35.24</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Source</em>: Health and Social Care Information Centre, National Childhood Measurement Programme.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T17:23:51.7999295Zmore like thismore than 2014-10-29T17:23:51.7999295Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4044
unstar this property label Biography information for Andrew Stephenson more like this
100404
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Obesity: Pendle more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, how many (a) men and (b) women in Pendle constituency were classified as (i) overweight and (ii) obese in each of the last 10 years. more like this
star this property tabling member constituency Pendle more like this
star this property tabling member printed
Andrew Stephenson more like this
star this property uin 211556 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>Data on adult obesity and excess weight (overweight and obese) for Pendle district are available from the ‘Local Health Profiles’ using data from the ‘Active People Survey’ commissioned by Sport England. The data are only available for 2012 and are presented as a total figure for males and females. This data is not collected by parliamentary constituency. The following data are for the area of Pendle district.</p><p> </p><p> </p><p> </p><p>Excess weight defined as the proportion of the adult population who are overweight or obese for Pendle district in 2012 was 67.7% (England 63.8%).</p><p> </p><p> </p><p> </p><p>The proportion of the adult population in Pendle district classified as obese in 2012 was 25.3% (England 23.0%).</p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T17:41:28.7700191Zmore like thismore than 2014-10-29T17:41:28.7700191Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4044
unstar this property label Biography information for Andrew Stephenson more like this
100419
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Temporary Employment more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, how much has been spent on agency and locum staff in the NHS (a) in total, (b) for each job type and (c) in each year since May 2010. more like this
star this property tabling member constituency Leicester South more like this
star this property tabling member printed
Jonathan Ashworth more like this
star this property uin 211600 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>Following the Francis<sup>1</sup> report many trusts were required to increase their spend on temporary staffing to meet safe staffing levels.</p><p> </p><p><br> The Department expects trusts to have a strong grip on their finances, and manage their contract and agency<sup>2</sup> staffing spend (including use of locums) responsibly through effective and efficient workforce planning and management and to minimise temporary staffing costs in future years.</p><p> </p><p> </p><p> </p><p>The amounts spent on agency and contract staff (including locums) in the National Health Service in each year since May 2010 are as follows:</p><p> </p><p> </p><p> </p><p>NHS Foundation Trusts<sup>3</sup></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2010-11</p></td><td><p>854.7</p></td></tr><tr><td><p>2011-12</p></td><td><p>907.0</p></td></tr><tr><td><p>2012-13</p></td><td><p>1,101.0</p></td></tr><tr><td><p>2013-14</p></td><td><p>1,396.2</p></td></tr><tr><td><p>Total</p></td><td><p>4,258.9</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>NHS Trusts</p><p> </p><p>This information is not available for NHS trusts for 2010-11 to 2012-13 as spend on agency and contract staff was not separately identified from other “non permanent NHS staff”<sup>4</sup>. The amount spent in 2013-14 on Contract and Agency staff by NHS trusts is £1,209.1m.</p><p> </p><p> </p><p> </p><p>The Department does not collect data on how much has been spent on agency and locum staff for each job type.</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><p> </p><p> </p><p><sup><sup>1</sup></sup> http://www.midstaffspublicinquiry.com/</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><sup>2</sup>The definition of Contract / Agency staff is: “Agency” employee payments for the employment of staff where the staff remain employees of the agency and “Contract staff” where the NHS trust has control over numbers and qualifications of staff (in contrast to a service obtained under contract).</p><p> </p><p> </p><p> </p><p><sup>3</sup> For 2009-10 – 2012-13 actual figures are based on gross staff costs as per notes in the NHS Foundation Trust consolidated accounts. The figures from the consolidated accounts may differ to the Board reports due to adjustments made on redundancy, early retirement, capitalisation of staff costs and costs of R&amp;D staff. 2013-14 figure is taken from the Department of Health Annual Report and Accounts 2013-14.</p><p> </p><p> </p><p> </p><p><sup>4</sup> The figures published for 2012-13 for NHS trusts are based on non-permanently employed staff which is defined as “others engaged on the objectives of the organisation and will include staff on inward secondment or loan from other organisations, bank/agency/temporary staff and contract staff.”</p><p> </p><p> </p><p> </p>
star this property answering member constituency Central Suffolk and North Ipswich more like this
star this property answering member printed Dr Daniel Poulter more like this
star this property question first answered
less than 2014-10-29T17:37:53.1376295Zmore like thismore than 2014-10-29T17:37:53.1376295Z
star this property answering member
3932
star this property label Biography information for Dr Dan Poulter more like this
star this property tabling member
4244
unstar this property label Biography information for Jonathan Ashworth more like this
100413
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Prostate Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, what steps he is taking to improve the diagnosis and treatment of prostate cancer. more like this
star this property tabling member constituency Birkenhead more like this
star this property tabling member printed
Mr Frank Field more like this
star this property uin 211632 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>Achieving earlier diagnosis of cancer is key to our ambition to save an additional 5,000 lives per year by 2014-15. We are investing £450 million to achieve early diagnosis of cancer through better public awareness, better screening and better access to key diagnostic tests.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) Referral Guidelines for Suspected Cancer (2005) are available to help general practitioners (GPs) assess when it is appropriate to refer patients for suspected cancer, including prostate cancer. NICE is in the process of updating the guidelines to ensure that these reflect latest evidence and can continue to support GPs to identify patients with suspected cancer symptoms and urgently refer them as appropriate. NICE’s anticipated publication date for the revised guidelines is May 2015.</p><p> </p><p> </p><p> </p><p>At a local level, it is for individual clinical commissioning groups to promote and enhance the diagnostic capability to deliver better outcomes. Surgery, radiotherapy and chemotherapy treatments that may be used for prostate cancer are commissioned at the moment by NHS England. NHS England’s prostate cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective prostate cancer services. This service specification has been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe core and developmental service standards.</p><p> </p><p> </p><p> </p><p>NICE published an updated clinical guideline on the diagnosis and treatment of prostate cancer in January 2014. NICE has recommended docetaxel, abiraterone and enzalutamide as treatment options for some types of prostate cancer, subject to certain clinical criteria and is currently appraising a number of other prostate cancer drugs. Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate. A number of drugs to treat prostate cancer are available through the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p>This Government is also investing in innovative radiotherapy treatments to improve outcomes for those with cancer. NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK into the use of Stereotactic Ablative Body Radiotherapy (SABR). This will allow patients to receive SABR treatment now, where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of these treatments so that in future, if it proves to be effective, they will be available for all relevant patients on the NHS. Two of these six trials will be on prostate cancer.</p><p> </p><p> </p><p> </p><p>We have also invested £23 million across 50 United Kingdom centres aimed at increasing the capacity of radiotherapy centres in England to deliver Intensity Modulated Radiotherapy (IMRT). We committed to achieving the ambition of 24% of all radiotherapy to be delivered through more accurate IMRT, and we are now seeing 35% of all radical radiotherapy treatments delivered using this method compared to 5% in 2010.</p><p> </p><p> </p><p> </p><p>The National Prostate Cancer Audit (NPCA) began collecting data in April 2014 and is due to publish the first of four annual reports during November 2014. The NPCA is the first national clinical audit of the care that men receive following a diagnosis of prostate cancer. It is designed to collect information about the diagnosis, management and treatment of every patient newly diagnosed with prostate cancer in England and Wales, and their outcomes. The findings from the audit will contribute to changes in clinical practice ensuring that patients receive the best care possible and experience an improved quality of life. The audit is funded by the Department and has been commissioned by the Healthcare Quality Improvement Partnership.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T16:57:06.3892444Zmore like thismore than 2014-10-29T16:57:06.3892444Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
478
unstar this property label Biography information for Lord Field of Birkenhead more like this
100410
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Hepatitis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
unstar this property question text To ask the Secretary of State for Health, with reference to the letter dated 7 March 2014 from the Minister for Public Health to the hon. Member for Kingston upon Hull North (reference POC4 845965) if he will place in the Library all documents in the possession of his Department relating to the advice received from an independent group of experts when the Skipton Fund was first established in 2003-04 in relation to the practicality of the State 1/Stage 2 Hepatitis C distinction. more like this
star this property tabling member constituency Kingston upon Hull North more like this
star this property tabling member printed
Diana Johnson more like this
star this property uin 211638 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-29
star this property answer text <p>We will arrange for all of the documents relating to the advice received from the group of independent experts which provided advice on the medical trigger for Skipton Fund stage 2 payments in 2003-04, to be placed in the Library by 14 November 2014.</p><p> </p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2014-10-29T17:17:54.6221085Zmore like thismore than 2014-10-29T17:17:54.6221085Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
1533
unstar this property label Biography information for Dame Diana Johnson more like this